Category Archives: Patent Eligible Subject Matter

Association For Molecular Pathology V Myriad Genetics – An Isolated Local Difficulty?

Posted on June 14, 2013 by Warren Woessner

Paul Cole, Professor of Intellectual Property Law at Bournemouth University and European Patent Attorney at Lucas & Co, Warlingham, Surrey, UK discusses yesterdays Myriad ruling by the Supreme Court. How does yesterday’s Supreme Court decision match international opinion on the patentability … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Supreme Court Rules In Myriad On Patentability Of DNA

Posted on June 13, 2013 by Warren Woessner

Today, the Supreme Court ruled that a naturally occurring DNA sequence is a product of nature, and not patent-eligible simply because it has been “isolated.” (A copy of the ruling can be found at the end of this post.) However, the … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 4 Comments

CLS Bank International v. Alice Corporation: Poison Apple

Posted on May 24, 2013 by Warren Woessner

This is a guest post from Ron Schutz of Robins, Kaplan, Miller & Ciresi. Move over Snow White.  A deeply-divided Federal Circuit in CLS Bank Int’l.  v. Alice Corp. Pty. Ltd., issued a per curiam opinion that dwarfs the scope … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

CLS Bank v. Alice Corp. (Part 2)

Posted on May 14, 2013 by Warren Woessner

I hope that some of my loyal readers noticed that my last post on CLS was incomplete, since it did not elaborate on the rationale for the decision(s) arrived at by the majority, either directly or by default. The first … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment